Market revenue in 2024 | USD 90.4 million |
Market revenue in 2030 | USD 127.7 million |
Growth rate | 5.9% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.59% in 2024. Horizon Databook has segmented the Argentina infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The infectious diseases molecular diagnostics market in Argentina is expected to be driven by increasing prevalence of infectious diseases during the forecast years. According to NCBI, in 2018, nearly 593,695 women suffered from recurrent vulvovaginal candidiasis in the country.
In addition, increasing incidence of HIV/AIDS is considered to be a major factor driving growth in the country. According to the World Bank in 2019, HIV infection had a prevalence rate of 0.1%. Hepatitis infection is also a major problem in the country.
All the abovementioned factors are likely to contribute to growth of the market in Argentina during the forecast period. In addition, lack of hospital facilities can increase severity of diseases in the country. However, commercialization of rapid test kits is likely to positively impact the infectious diseases molecular diagnostics market.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Argentina infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account